Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.

Lighthouse Festival Preparing for 2027
Province Invests More in Niagara Health
Flooding Relief on List for AMO
Over $40,000 Raised for Day of Giving
Police Concerned After Man Released
Body Found During Home Demolition
2 Men Wanted After Lincoln Break In
Boy Severely Hurt in Lundy's Collision